Buy Geftinat 250 mg

Buy Geftinat 250 mg used as the first-line treatment of patients with pathological process non-small cell carcinoma (NSCLC) whose tumours have stratum protein receptor (EGFR) coding DNA nineteen deletions or coding DNA twenty-one (L858R) substitution mutations as detected by FDA. The upkeep treatment of patients with domestically advanced or pathological process non-small cell carcinoma whose illness has not progressed once four cycles of platinum-based first-line therapy.

Buy Geftinat 250 mg are used as first line therapy to treat locally advanced (stage III) or metastatic (stage IV) non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and grows more slowly than small cell lung cancer (SCLC). For Geftinat tablets 250 mg to be an effective treatment for NSCLC a specific type of gene mutation should be identified and present in the tumour cells.